Eos posts explosive Q2 growth, a $19B pipeline, and benefits from federal support, despite modest dilution and high valuation. See why EOSE stock is a strong buy.

Prescription digital therapeutics (PDTs) are FDA-regulated tools that deliver evidence-based interventions via software, and they may help to address these gaps in mental health care for depression, ...

Discover how OpenAI's Sora 2 challenges Adobe's creative software dominance and what it means for ADBE investors. Click here to read my ADBE stock update.

The NuPhy Air75 V3 is one of the best low-profile keyboards to date, and it's all due to its fantastic switches, acoustics, and layered construction.